Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome

Clinical trial NCT07114055 · RECRUITING

Trial details

NCT number: NCT07114055
Sponsor: Md. Hazrat Ali
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Irritable Bowel Syndrome - Diarrhoea

Start date: 2025-08-15
Primary completion: 2026-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.